Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialAimery de Gramont, Paulo M. Hoff, G. Bodoky et al.|The Lancet Oncology|2012Cited by 526